DESPITE low sales results, due in
part to generic competition for Lipitor,
Pfizer has reported higher-thanexpected
profits for its third quarter.
Earlier estimations forecast Pfizer
to come out with US51c per share
profits for the period, however the
drug company announced profit of
US54c (excluding Wyeth acquisition
costs).
The better than expected results
are being put down to staff cuts,
and the acquisition of Wyeth.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Nov 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Nov 10
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.